Microsurgery in the Sickle Cell Trait Population: Can it Be Safely and Successfully Performed?

Summary:. Free-tissue transfer reconstruction in patients with sickle cell anemia risks failure due to polymerization of sickle hemoglobin within the flap microcirculation. However, outcomes vary, as the amount of polymerization is dependent on factors such as disease phenotype/diagnosis, degree of...

Full description

Bibliographic Details
Main Authors: Sara Eliseo, MS, Levana Berlin, DO, Ahmed M. Mansour, MD, Susan Hansen, MA, Bharat Ranganath, MD, Sean J. Wallace, MD, MS
Format: Article
Language:English
Published: Wolters Kluwer 2023-11-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000005377
_version_ 1797449469858414592
author Sara Eliseo, MS
Levana Berlin, DO
Ahmed M. Mansour, MD
Susan Hansen, MA
Bharat Ranganath, MD
Sean J. Wallace, MD, MS
author_facet Sara Eliseo, MS
Levana Berlin, DO
Ahmed M. Mansour, MD
Susan Hansen, MA
Bharat Ranganath, MD
Sean J. Wallace, MD, MS
author_sort Sara Eliseo, MS
collection DOAJ
description Summary:. Free-tissue transfer reconstruction in patients with sickle cell anemia risks failure due to polymerization of sickle hemoglobin within the flap microcirculation. However, outcomes vary, as the amount of polymerization is dependent on factors such as disease phenotype/diagnosis, degree of hypoxia, and intracellular dehydration. Most of the literature focuses on patients with sickle cell disease, which produces higher concentrations of sickle hemoglobin and, therefore, is a contraindication to microvascular reconstruction. Fewer reports describe microsurgery in patients with sickle cell trait (SCT) who carry the heterozygous phenotype. Here, we present a case in which a patient with SCT underwent microsurgical breast reconstruction with deep inferior epigastric perforator free-tissue transfer. The 52-year-old woman had previously experienced a failed alloplastic-based reconstruction after radiation therapy for breast cancer. In our case, clinical and Doppler examinations demonstrated that arterial and venous anastomoses had remained patent; so the patient was discharged on postoperative day 4. Blistering developed on postoperative day 8, and by day 15 there was partial necrosis of the inferior-lateral aspect of the deep inferior epigastric perforator flap. Debridement and closure resolved the issue, and at 5 months postprocedure, the flap remained well-perfused and well-incorporated. This case, presented here with patient consent, reports a successful outcome of microsurgical reconstruction in a patient with SCT. It expands the limited evidence to support the safety and feasibility of autologous surgical interventions for patients with the heterozygous phenotype of sickle cell anemia.
first_indexed 2024-03-09T14:26:31Z
format Article
id doaj.art-189aa3db69b6408c92c978779bb84779
institution Directory Open Access Journal
issn 2169-7574
language English
last_indexed 2024-03-09T14:26:31Z
publishDate 2023-11-01
publisher Wolters Kluwer
record_format Article
series Plastic and Reconstructive Surgery, Global Open
spelling doaj.art-189aa3db69b6408c92c978779bb847792023-11-28T07:10:12ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742023-11-011111e537710.1097/GOX.0000000000005377202311000-00014Microsurgery in the Sickle Cell Trait Population: Can it Be Safely and Successfully Performed?Sara Eliseo, MS0Levana Berlin, DO1Ahmed M. Mansour, MD2Susan Hansen, MA3Bharat Ranganath, MD4Sean J. Wallace, MD, MS5From * Philadelphia College of Osteopathic Medicine, Moultrie, Ga.† Lehigh Valley Health Network, Allentown, Pa.† Lehigh Valley Health Network, Allentown, Pa.† Lehigh Valley Health Network, Allentown, Pa.‡ George Washington University Plastic Surgery, Washington, D.C.‡ George Washington University Plastic Surgery, Washington, D.C.Summary:. Free-tissue transfer reconstruction in patients with sickle cell anemia risks failure due to polymerization of sickle hemoglobin within the flap microcirculation. However, outcomes vary, as the amount of polymerization is dependent on factors such as disease phenotype/diagnosis, degree of hypoxia, and intracellular dehydration. Most of the literature focuses on patients with sickle cell disease, which produces higher concentrations of sickle hemoglobin and, therefore, is a contraindication to microvascular reconstruction. Fewer reports describe microsurgery in patients with sickle cell trait (SCT) who carry the heterozygous phenotype. Here, we present a case in which a patient with SCT underwent microsurgical breast reconstruction with deep inferior epigastric perforator free-tissue transfer. The 52-year-old woman had previously experienced a failed alloplastic-based reconstruction after radiation therapy for breast cancer. In our case, clinical and Doppler examinations demonstrated that arterial and venous anastomoses had remained patent; so the patient was discharged on postoperative day 4. Blistering developed on postoperative day 8, and by day 15 there was partial necrosis of the inferior-lateral aspect of the deep inferior epigastric perforator flap. Debridement and closure resolved the issue, and at 5 months postprocedure, the flap remained well-perfused and well-incorporated. This case, presented here with patient consent, reports a successful outcome of microsurgical reconstruction in a patient with SCT. It expands the limited evidence to support the safety and feasibility of autologous surgical interventions for patients with the heterozygous phenotype of sickle cell anemia.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000005377
spellingShingle Sara Eliseo, MS
Levana Berlin, DO
Ahmed M. Mansour, MD
Susan Hansen, MA
Bharat Ranganath, MD
Sean J. Wallace, MD, MS
Microsurgery in the Sickle Cell Trait Population: Can it Be Safely and Successfully Performed?
Plastic and Reconstructive Surgery, Global Open
title Microsurgery in the Sickle Cell Trait Population: Can it Be Safely and Successfully Performed?
title_full Microsurgery in the Sickle Cell Trait Population: Can it Be Safely and Successfully Performed?
title_fullStr Microsurgery in the Sickle Cell Trait Population: Can it Be Safely and Successfully Performed?
title_full_unstemmed Microsurgery in the Sickle Cell Trait Population: Can it Be Safely and Successfully Performed?
title_short Microsurgery in the Sickle Cell Trait Population: Can it Be Safely and Successfully Performed?
title_sort microsurgery in the sickle cell trait population can it be safely and successfully performed
url http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000005377
work_keys_str_mv AT saraeliseoms microsurgeryinthesicklecelltraitpopulationcanitbesafelyandsuccessfullyperformed
AT levanaberlindo microsurgeryinthesicklecelltraitpopulationcanitbesafelyandsuccessfullyperformed
AT ahmedmmansourmd microsurgeryinthesicklecelltraitpopulationcanitbesafelyandsuccessfullyperformed
AT susanhansenma microsurgeryinthesicklecelltraitpopulationcanitbesafelyandsuccessfullyperformed
AT bharatranganathmd microsurgeryinthesicklecelltraitpopulationcanitbesafelyandsuccessfullyperformed
AT seanjwallacemdms microsurgeryinthesicklecelltraitpopulationcanitbesafelyandsuccessfullyperformed